There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

world

This magazine is from a federated server and may be incomplete. Browse more on the original instance.

Ukrainian forces appear to widen breach of Russian defenses on southern front lines (edition.cnn.com)

Signs are growing that Ukrainian forces have penetrated Russian defenses along part of the southern front lines in Zaporizhzhia region and are expanding a wedge toward the strategic town of Tokmak, while stepping up attacks on Russian-occupied Crimea....

Mexico’s President Andres Manuel López Obrador has condemned Texas’s anti-migrant buoys, calling the border enforcement tactic on the Rio Grande river “inhumane” after bodies were found in the waters (www.cnn.com)

he floating barrier, which is intended to block migrants crossing from Mexico, was installed last month without federal authorization, according to the US Justice Department, which is suing the state of Texas over its use of the buoys....

Macron walks tightrope as French police protest challenges rule of law (www.france24.com)

National police chief: “a police officer should not be in prison, even if he may have committed serious faults or errors in the course of his work.” Left-wing opposition blasted government for failing to rein in “a police hierarchy that places itself above the law”.

French Courts Are Giving Protesters INSANE Sentences (www.youtube.com)

French courts have been imposing disproportionately severe sentences for minor offenses, including 10 months in prison for stealing a can of Red Bull and one year for a homeless boy with schizophrenia caught looting a luxury store. The overwhelmed courts rush cases, provide minimal time for defendants, and prioritize punishment...

The first drug that slows Alzheimer's has finally received FDA approval (www.engadget.com)

Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines